Overview of Cevit

Quick Facts

Property	Description
Active Ingredient	Sodium Ascorbate and/or Ascorbic Acid
Form	Oral Tablet, Chewable Tablet, Capsule, or Sterile Solution
Pharmacological Class	Vitamin (Water-Soluble Vitamin), Antioxidant
Common Use	Supplementation to prevent or correct Vitamin C deficiency
Origin	Typically Synthetic (Derived from L-Ascorbic Acid)

What Type of Medicine is Cevit? (Definition and Classification)

Cevit is a pharmaceutical preparation primarily classified as a Vitamin and a Nutritional Supplement, delivering the essential water-soluble vitamin known as Vitamin C (Ascorbic Acid). It belongs to the high-level pharmacological class of Vitamin C Preparations and functions critically as an Antioxidant within the body's protective systems. Pharmacological studies support the necessity of this medicine, confirming that because the human body cannot produce L-Ascorbic Acid on its own, a continuous exogenous source is required to fulfill essential metabolic requirements. Cevit is widely positioned for everyday support and prevention of general deficiency in various patient groups.

Composition and Forms: Sodium Ascorbate vs. Ascorbic Acid

The core active ingredient in Cevit is Sodium Ascorbate, which is the neutral salt form of Vitamin C and is often combined with pure Ascorbic Acid. Chemically, Sodium Ascorbate is known as Monosodium L-ascorbate. The active ingredient in commercial preparations is typically synthetic in origin, though chemically identical to its natural counterpart. The key differentiating feature of preparations utilizing Sodium Ascorbate is its buffered nature. This salt form makes the preparation generally less acidic than products containing only Ascorbic Acid, which is clinically recognized to offer better gastric tolerability, particularly for sensitive individuals. Cevit is supplied in various dosage forms, most commonly as an Oral Tablet, Chewable Tablet, or Capsule, alongside specialized sterile Solution preparations for parenteral administration.

General Purpose and Core Biological Function

The fundamental purpose of Cevit is to supply the body with Vitamin C to support systemic health and correct a nutritional deficiency. This is achieved through its primary physiological actions of acting as an indispensable cofactor required for collagen synthesis—which supports the structural integrity of connective tissues, bones, and blood vessels—and acting as a potent antioxidant to neutralize free radicals. This general support ensures the maintenance of tissue health and overall metabolic balance by aiding various enzymatic processes, a function universally confirmed across medical literature.

What side effects are possible with Cevit?

Possible Side Effects and Safety Information

The official safety information for Cevit (Ascorbic Acid/Sodium Ascorbate) outlines adverse reactions primarily associated with high intake and specific patient conditions, classifying most effects as less common or rare in regulatory documents.

Documented Adverse Reactions

Adverse reactions are officially grouped by the body systems they affect:

Gastrointestinal Disorders: Effects documented include diarrhea, nausea, vomiting, and stomach cramps. Diarrhea is typically reported with doses exceeding 2 g daily.
Nervous System Disorders: Reactions listed in safety summaries include headache and, less frequently, dizziness or faintness (often related to rapid intravenous administration).
Renal and Urinary Disorders: Increased urination (diuresis) is an effect, and high doses are linked to increased urinary oxalate excretion.
Vascular and Skin Disorders: Officially documented effects include flushing and redness of the skin.

Serious Adverse Reactions and Safety Constraints

Specific serious adverse reactions are documented in official labeling, largely conditional on exposure or pre-existing health status:

Condition/Risk	Regulatory Context
Oxalate Nephropathy/Nephrolithiasis	Risk associated with the prolonged use of high doses (kidney stone formation).
Acute Hemolytic Anemia	Documented risk in individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.
Contraindications	Should not be used in individuals with pre-existing hyperoxaluria or known hypersensitivity.

Patients with renal disease or a history of oxalate kidney stones are identified in safety documents as being at increased risk for nephrolithiasis. Furthermore, the medicine can interfere with certain laboratory tests based on oxidation-reduction, potentially affecting results for urinary glucose or faecal occult blood.

Overdose and Emergency Response

Overdose and When to Seek Help

The following information is based strictly on the officially documented overdose statements found in government-authorized prescribing information for Cevit (Ascorbic Acid).

Overdose Scope

Classification	Detail (As Stated in Official Labeling)
Documented Overdose Presentations	Symptoms often associated with high supplemental intake (over 2 grams per day) include gastrointestinal disturbances, such as nausea, diarrhea, stomach cramps, and heartburn.
Physiological Systems Affected	The renal system is the main focus due to the potential for oxalate nephropathy or nephrolithiasis (kidney stones) with prolonged use of high doses, especially in at-risk populations.
Population-Specific Overdose Notes	Patients with pre-existing renal disease, a history of oxalate kidney stones, or glucose-6-phosphate dehydrogenase (G6PD) deficiency are at an increased risk of serious complications, including severe hemolysis (in G6PD deficiency).

Required Emergency Action

Statement	Official Phrasing
Emergency-Response Statement	The management of overdosage is generally supportive and symptomatic.
When Immediate Medical Help is Required	Seek immediate medical attention for any suspected overdose or if severe symptoms, such as acute pain suggestive of kidney stone formation, occur.

Connection to the Overall Overdose Profile

The regulatory profile defines the overdose risk primarily by identifying the specific gastrointestinal and renal complications that occur with intake substantially above the recommended upper limits. This structure establishes the criteria for a serious event (e.g., severe renal or hematological effects) and mandates that all suspected cases require immediate professional evaluation. Symptomatic and supportive management is the standard labeled procedure, focusing on treating the specific manifestations of toxicity observed.

Therapeutic Uses of Cevit

What Cevit Treats: Main Uses and Benefits

Cevit (Ascorbic Acid/Sodium Ascorbate) provides fundamental therapeutic support by addressing nutritional insufficiency and managing the physiological consequences of deficiency. Its applications generally center on supporting systemic integrity and enhancing the body's resilience.

This medication is commonly used to help address the classic severe Vitamin C deficiency known as scurvy and is relevant for managing symptoms that interfere with daily comfort, such as fatigue, malaise, and muscle weakness. It is applied in addressing symptoms related to physical discomfort, such as easy bruising, bleeding gums, and issues with poor wound healing.

Correcting Deficiency and Supporting Tissue Integrity

Cevit is applied across therapeutic domains involving symptoms related to systemic imbalance. This supportive intervention may assist with managing symptoms that create noticeable physiological strain related to deficiency. The benefit supports the structural strength of blood vessel walls and connective tissues, which assists with maintaining functional stability.

Relevant in High-Demand Clinical Scenarios

Cevit is commonly used to help with conditions marked by increased physiological stress, such as recovery following burns, trauma, or surgery, and in patients with chronic malabsorption syndromes. This targeted support contributes to improved comfort during periods of heightened symptoms.

Quick Fact: Relief for Vascular Fragility

Symptom Addressed	Clinical Context	Patient Benefit
Bleeding gums and easy bruising	Acute deficiency and high-demand states	Supports structural strength of blood vessel walls
Poor wound healing and tissue weakness	Post-operative and trauma recovery	Assists with maintaining functional stability

Regulatory References

NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Cevit

Cevit (multivitamins for infusion) is officially indicated for adults and children aged over 11 years who require multi-vitamin supplementation via the parenteral route because oral nutrition is insufficient or impossible.

Classification	Populations & Conditions (Official Labeling)
Contraindicated	Use is prohibited for patients with:
	• Hypersensitivity (allergy) to any active substance, especially Vitamin B1 (Thiamine), or to excipients, including soy protein/products or peanut protein/products (due to cross-reactivity).
	• Pre-existing hypervitaminosis (excessive amounts of any vitamin in the formulation already stored in the body).
	• Children under 11 years of age.
Use Requires Special Caution	Use is permitted but requires close monitoring for patients with:
	• Renal impairment or hepatic impairment (increased risk of Vitamin A toxicity).
	• Concurrent use of additional vitamins from other sources (risk of cumulative overdose).
	• Vitamin B12 deficiency (requires status evaluation before long-term use).
Pregnancy and Lactation	Use is not recommended during breastfeeding due to the risk of Vitamin A overdose in the infant. It may be prescribed during pregnancy if clearly needed, with careful dose consideration to avoid vitamin overdose.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Cevit (Ascorbic Acid/Sodium Ascorbate) is officially documented by regulatory authorities, focusing on specific substance constraints and exposure modification patterns. Co-administration may alter the plasma concentrations of certain medicines or increase toxicity risks.

Regulatory labels document that Cevit can cause urine acidification, resulting in decreased serum levels and increased renal excretion of substances such as Amphetamine and Fluphenazine. Cevit also increases the oral absorption of iron from co-administered supplements. Conversely, the plasma concentration of Cevit itself is documented to be decreased by substances including Oral Contraceptives and Salicylates.

Specific restrictions and advisories exist for particular combinations:

Deferoxamine (Desferrioxamine): Co-administration may increase the risk of cardiac adverse effects in patients with iron overload and requires careful monitoring.
Aluminum-containing Antacids: Concurrent use is not recommended in patients with renal insufficiency due to the potential for increased aluminum toxicity.
Amygdalin: Co-administration with this complementary medicine is officially documented to carry a risk of cyanide toxicity.

High doses of Cevit are documented to potentially decrease the activities of certain antibiotics. Furthermore, the regulatory labels note that Alcohol consumption and Tobacco Smoking both decrease the plasma concentration of Ascorbate.

Mechanism of Action

How Cevit Works: Mechanism of Action

Cevit operates through three primary mechanistic domains, centered on its function as a cofactor and a reductant. It acts as an essential cofactor for specific hydroxylase enzymes, notably prolyl-4-hydroxylase and lysyl hydroxylase, which are required for the post-translational modification (hydroxylation) of amino acids within collagen precursors. This crucial process drives the formation of the stable, triple-helix structure of collagen, thereby supporting the structural integrity of connective tissues, including blood vessels and bone matrix.

Simultaneously, Cevit functions as a reductant by readily donating electrons to neutralize harmful free radicals and reactive oxygen species (ROS). This mechanism contributes to the body's antioxidant defense system, supporting the maintenance of molecular integrity within cells.

Furthermore, Cevit is a required cofactor for other metabolic enzymes, such as dopamine beta-hydroxylase, necessary for the conversion of dopamine to norepinephrine, and those involved in carnitine synthesis. This modulates key energy and chemical signaling pathways, providing the requisite biochemical resources for nerve communication and cellular energy production.

Dosage and Administration Information

How to Use Cevit: Official Dosing and Administration

Cevit (Ascorbic Acid or Sodium Ascorbate) administration depends strictly on the clinical requirement and the patient's ability to take medication orally. The oral route is the most common for maintenance and non-acute therapeutic use. Parenteral administration (Intravenous, Intramuscular, or Subcutaneous) is reserved for short-term scurvy treatment when oral intake is compromised or insufficient.

Standard Dosing Regimens

Dosing is based on the therapeutic goal, distinguishing between daily prevention and acute treatment.

Indication	Route	Standard Dosing Regimen	Duration Constraint
Scurvy Treatment	Oral	100 to 250 mg once or twice daily	Minimum of two weeks
Scurvy Treatment	Intravenous (IV)	200 mg once daily	Maximum recommended duration is seven days
Deficiency Prophylaxis	Oral	50 to 200 mg once daily	Varies by individual and context

Administration Requirements

Oral forms, such as tablets, are typically taken with water; chewable forms must be chewed completely before swallowing. Injectable preparations of ascorbic acid must be diluted in a suitable intravenous solution (such as Dextrose 5%) prior to use. This diluted solution must then be administered as a slow intravenous infusion. Due to light sensitivity, exposure of the sterile solution must be minimized.

In special populations, such as those with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency or during pregnancy and lactation, intake should not exceed the U.S. Recommended Dietary Allowance (RDA).

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cevit

This overview summarizes the available research regarding Cevit (Ascorbic Acid / Sodium Ascorbate) according to authoritative scientific and regulatory sources. It describes the types of studies conducted, the outcomes they measured, and areas where evidence remains uncertain.

Evidence Supporting Correction of Severe Deficiency

Research exploring the role of this preparation in addressing severe Vitamin C deficiency (Scurvy) has been compiled from historical clinical experience, case reports, and case series documented over decades. Modern, large-scale, placebo-controlled trials are not typically conducted for this condition, as its link to Vitamin C status is widely confirmed by authoritative medical sources.

Research examined changes in the characteristic physiological manifestations of deficiency, such as the cessation of bleeding gums and easy bruising, changes observed in the healing of skin and tissues, and in severe fatigue and malaise. Studies reported patterns observed in the measured change in the deficiency symptoms and documented shifts in low Vitamin C concentrations toward the defined normal ranges. However, the existing data provides limited comparative evidence against placebo, as such trials are generally considered unethical.

Research on Nutritional Insufficiency and Status Maintenance

Research exploring the role of Cevit for nutritional insufficiency has utilized various designs, including Randomized Controlled Trials (RCTs), Systematic Reviews, and Prospective Cohort Studies. These studies aimed to understand how supplementation relates to the maintenance of circulating Vitamin C levels and related systemic balance.

The main outcomes monitored included precise biomarker measurements of Vitamin C concentration in the blood, and patient-reported outcomes describing perceived discomfort or general physical functioning. Research highlights that the preparation was observed in studies to consistently raise and maintain Vitamin C concentrations. However, findings related to broader, functional outcomes (such as overall daily activity level or changes in symptoms related to systemic imbalance) lacked consistency and were highly dependent on the study population's initial Vitamin C status.

Evidence Gaps and Research Uncertainty

The research describes what is known and what is still uncertain about Cevit beyond its primary purpose of correcting known deficiency. Key limitations cited in the literature include the modest sample sizes and high methodological variability found in many of the studies conducted outside of deficiency correction.

For its studied use in critical illness (high-demand physiological scenarios), the trials show mixed findings, and the comparative evidence is lacking to definitively establish a uniform pattern of impact on major clinical outcomes such as mortality. Furthermore, there is limited information for long-term outcomes across various special populations, meaning that the research provides context but not individual predictions about sustained functional health.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Cevit (FAQ)

Q: Are there any common over-the-counter pain relievers that interact with Cevit?

Official product information indicates that Cevit may interact with some over-the-counter pain relievers. Regulatory documents state that the class of medicines known as Salicylates (including certain aspirin products) may decrease the plasma concentration of Cevit in the body. This interaction is documented in official product information.

Q: Can Cevit be used by teenagers or children?

Regulatory documents provide specific administration guidance for the injectable form of the drug for pediatric patients (children aged 5 months and older) in deficiency cases. For oral forms, the official labeling supports use only with professional evaluation for certain age groups. Eligibility for use is determined by the specific formulation and the patient’s clinical need.

Q: Are there any specific foods or drinks to avoid while using Cevit?

The official product information lists interactions with certain substances that can affect the concentration of Cevit in the body. Specifically, regulatory documents state that both alcohol consumption and tobacco smoking are documented to be associated with decreased levels of Cevit (Ascorbate) in the blood. No specific interactions with general foods are typically documented in official product labels.

Q: Are there any long-term effects of taking Cevit for an extended time?

Official safety information addresses potential effects associated with high-dose use over extended periods. Official safety information indicates that the prolonged use of high doses is associated with a risk of oxalate nephropathy, which is the formation of kidney stones. For example, the injectable form is generally not indicated for prolonged administration.

Q: Does Cevit need to be kept refrigerated?

According to the official storage requirements, Cevit should be stored in a cool, dry place, typically at a controlled room temperature (e.g., 15-30 C). Regulatory documents explicitly require the product to be kept from freezing. Official storage requirements do not require refrigeration.

Q: Are there any known interactions between Cevit and herbal remedies?

The official interaction profile may document constraints related to specific non-traditional medicines. For instance, regulatory labels describe the co-administration of Cevit with Amygdalin as carrying a risk of cyanide toxicity. However, official documents do not typically provide a general list covering all possible herbal or complementary remedies.

Q: Can Cevit be crushed or split, or must it be swallowed whole?

Administration instructions depend on the specific formulation being used. Official guidance for chewable tablets states that they are intended to be chewed completely before swallowing. If the product is an extended-release or enteric-coated form, it is required to be swallowed whole to ensure it works as intended.

Q: What are the signs that Cevit might not be working correctly?

If symptoms of deficiency continue despite taking Cevit, this may be a sign that the treatment is not having the intended effect. Official studies have observed that deficiency symptoms, such as fatigue and poor wound healing, begin to show improvement within a typical timeframe, often up to four weeks of consistent treatment.

Q: How quickly does Cevit start working after you take it?

The time it takes to see the clinical effect of Cevit can vary. Studies indicate that symptoms of a known deficiency may take up to four weeks of consistent oral supplementation before improvement is observed. While intravenous administration rapidly achieves higher concentrations in the blood, the speed of overall clinical effect has been observed to vary.

Q: If I miss a dose of Cevit, what typically happens?

Official drug information describes the procedure where, if a dose is missed, it is taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose is skipped entirely. Official guidance states that taking a double dose is not recommended to make up for a missed one.

Q: Can Cevit be taken with food, or does it need to be on an empty stomach?

According to authoritative drug information, Cevit can generally be taken with or without food as directed by a healthcare provider. Taking the supplement with food is a common strategy to help reduce the potential for mild stomach upset.

Q: Does taking Cevit make you feel sleepy or tired?

The official safety information documents potential effects related to the nervous system. Adverse reactions listed include headache, dizziness, and difficulty falling asleep or staying asleep. Furthermore, fatigue is also cited in safety summaries as a possible adverse effect.

Q: Is Cevit safe for elderly people to take?

The official safety documentation highlights that geriatric patients may be at an an increased risk for certain serious adverse reactions, specifically oxalate nephropathy (kidney stones). Official documentation notes that this increased risk supports the need for careful professional oversight for elderly individuals.

Q: How long do the effects of Cevit typically last in the body?

Cevit is a water-soluble vitamin, and the body maintains a tight control over its circulating levels. Following high-dose administration, the excess is rapidly excreted by the kidneys within a few hours. At standard physiological doses, plasma concentrations are tightly controlled by the body's reabsorption mechanisms.

Q: Is it safe to drive or operate machinery while taking Cevit?

Official safety information does not contain a broad prohibition on driving. However, documented adverse reactions, such as temporary dizziness and faintness, particularly when administered intravenously, official documents note that these effects may temporarily influence the ability to drive or operate machinery.

Q: What happens if I accidentally take two doses of Cevit close together?

Overdose information documents that intakes greater than 3,000 mg per day for adults have been associated with common issues like diarrhea and other gastrointestinal disturbances. Official guidance states that taking a double dose is not recommended to make up for a missed one.

Q: How is Cevit processed or eliminated from the body?

Cevit, being a water-soluble vitamin, is primarily processed and eliminated through the renal system (the kidneys). Regulatory documents state that once the plasma levels are saturated, any excess Cevit that is not used by the body is largely excreted in the urine.

Q: What are the non-active ingredients in Cevit?

Official documentation, such as the DailyMed label, lists the excipients (non-active ingredients) used in the product. These ingredients vary widely by the specific formulation but may include fillers, coatings, and flavorings. Some formulas are specifically noted as not containing dyes, fillers, or preservatives.

Q: Can I stop taking Cevit as soon as I feel better?

Official dosing regimens for treating established deficiency, such as scurvy, specify a minimum duration of treatment, for example, two weeks for oral use. This indicates that the specified duration is generally linked to achieving the intended therapeutic goal.

Q: Is Cevit a controlled substance?

Official drug classification from regulatory bodies confirms that Cevit (Ascorbic Acid) is classified as a Dietary Supplement or Vitamin. It is not listed as a controlled substance by government agencies like the Drug Enforcement Administration.

Q: Does the time of day matter when taking Cevit?

Official administration instructions generally state that the product is to be taken once a day or as directed by a healthcare professional. Regulatory labels do not specify a mandatory fixed time of day (morning or night), indicating that the effect is not acutely dependent on the timing.

How should Cevit be stored and disposed of?

Official Storage and Disposal Requirements

Storage Conditions: Cevit (Ascorbic Acid) must be stored below 30 C in a cool, dry place. Regulatory documents explicitly require the product be protected from light and protected from moisture to maintain stability. The container must be kept tightly closed and stored in its original package.

Handling and Safety: Keep the medicine out of the reach of children. It is mandatory to keep from freezing and keep away from heat to prevent degradation of the active ingredient.

Disposal Rules: Unused or expired Cevit should be disposed of at an approved waste disposal plant or special waste collection point in accordance with local environmental regulations. Do not empty the product into drains or waterways.

Cevit